95 related articles for article (PubMed ID: 21249323)
1. Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound.
Hoshi H; Saito H; Iijima H; Uchida M; Wada T; Ito G; Tanaka H; Sawada T; Hirakawa K
Oncol Rep; 2011 Apr; 25(4):905-13. PubMed ID: 21249323
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line.
Kanoh T; Saito K; Matsunaga K; Oguchi Y; Taniguchi N; Endoh H; Yoshimura M; Fujii T; Yoshikumi C
In Vivo; 1994; 8(2):241-5. PubMed ID: 7919129
[TBL] [Abstract][Full Text] [Related]
3. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
Ebina T; Kohya H; Ishikawa K
Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
Ebina T; Kohya H
Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of a protein-bound polysaccharide, PSK, against Candida albicans infection in syngeneic tumor-bearing mice via Th1 cell functions.
Ohmura Y; Matsunaga K; Motokawa I; Sakurai K; Ando T
Cancer Biother Radiopharm; 2003 Oct; 18(5):769-80. PubMed ID: 14629825
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
Ebina T; Murata K
Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
[TBL] [Abstract][Full Text] [Related]
9. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antitumor effect of tegafur/uracil (UFT) plus leucovorin by combined treatment with protein-bound polysaccharide, PSK, in mouse models.
Katoh R; Ooshiro M
Cell Mol Immunol; 2007 Aug; 4(4):295-9. PubMed ID: 17764620
[TBL] [Abstract][Full Text] [Related]
11. [Induction of manganese superoxide dismutase by an immunopotentiator as a mechanism of inhibiting of malignant progression of murine tumor cells].
Habelhah H
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):519-29. PubMed ID: 9846281
[TBL] [Abstract][Full Text] [Related]
12. Protein-bound polysaccharide-K reduces the proportion of regulatory T cells in vitro and in vivo.
Aoki R; Iijima H; Kato M; Uchida M; Wada T; Murata M; Ogawa K; Naritaka Y; Yoshimatsu K
Oncol Rep; 2014 Jan; 31(1):50-6. PubMed ID: 24190620
[TBL] [Abstract][Full Text] [Related]
13. Polysaccharide K and Coriolus versicolor extracts for lung cancer: a systematic review.
Fritz H; Kennedy DA; Ishii M; Fergusson D; Fernandes R; Cooley K; Seely D
Integr Cancer Ther; 2015 May; 14(3):201-11. PubMed ID: 25784670
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].
Ebina T; Kohya H; Inoue H; Aso H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1841-6. PubMed ID: 2439019
[TBL] [Abstract][Full Text] [Related]
15. Production of antiserum against antitumor protein-bound polysaccharide preparation, PSK (Krestin) and its pharmacological application.
Endoh H; Matsunaga K; Yoshikumi C; Kawai Y; Suzuki T; Nomoto K
Int J Immunopharmacol; 1988; 10(2):103-9. PubMed ID: 3372106
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
Ebina T; Kohya H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
[TBL] [Abstract][Full Text] [Related]
17. A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.
Yamasaki A; Shoda M; Iijima H; Nagai S; Wada J; Suzuki H; Chikazawa N; Tasaka T; Kameda C; Tanaka H; Ikebe M; Jo E; Sato N; Nakamura M; Sekine F; Morisaki T; Katano M
Anticancer Res; 2009 Mar; 29(3):843-50. PubMed ID: 19414318
[TBL] [Abstract][Full Text] [Related]
18. Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK.
Kanoh T; Matsunaga K; Saito K; Fujii T
In Vivo; 1994; 8(2):247-50. PubMed ID: 7522606
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of a protein-bound polysaccharide, PSK, on Candida albicans infection in mice via tumor necrosis factor-alpha induction.
Ohmura Y; Matsunaga K; Motokawa I; Sakurai K; Ando T
Int Immunopharmacol; 2001 Sep; 1(9-10):1797-811. PubMed ID: 11562071
[TBL] [Abstract][Full Text] [Related]
20. [Differences of antitumor effect of various BRMs by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
